These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 3130106

  • 1. Heterogeneity in human acid beta-glucosidase revealed by cellulose-acetate electrophoresis.
    Sa Miranda MC, Aerts JM, Pinto RA, Magalhaes JA, Barranger JA, Tager JM, Schram AW.
    Biochim Biophys Acta; 1988 May 12; 965(2-3):163-8. PubMed ID: 3130106
    [Abstract] [Full Text] [Related]

  • 2. Qualitative characteristics of the beta-glucosidase isozymes.
    Choy FY, Davidson RG.
    Prog Clin Biol Res; 1982 May 12; 95():415-41. PubMed ID: 6812079
    [No Abstract] [Full Text] [Related]

  • 3. Gaucher's disease. I. Solubilization and electrophoresis of beta-glucosidase from leukocytes and cultured fibroblasts.
    Choy FY, Davidson RG.
    Pediatr Res; 1978 Dec 12; 12(12):1115-20. PubMed ID: 106357
    [No Abstract] [Full Text] [Related]

  • 4. Gaucher disease: the effects of phosphatidylserine on glucocerebrosidase from normal and Gaucher fibroblasts.
    Choy FY.
    Hum Genet; 1984 Dec 12; 67(4):432-6. PubMed ID: 6436168
    [Abstract] [Full Text] [Related]

  • 5. Electrophoretic separation of neutral and acid beta-glucosidase isozymes in human tissues.
    Shafit-Zagardo B, Devine EA, Desnick RJ.
    Biochim Biophys Acta; 1980 Aug 07; 614(2):459-65. PubMed ID: 6773581
    [Abstract] [Full Text] [Related]

  • 6. Relationship between the two immunologically distinguishable forms of glucocerebrosidase in tissue extracts.
    Aerts JM, Donker-Koopman WE, van Laar C, Brul S, Murray GJ, Wenger DA, Barranger JA, Tager JM, Schram AW.
    Eur J Biochem; 1987 Mar 16; 163(3):583-9. PubMed ID: 3830174
    [Abstract] [Full Text] [Related]

  • 7. Use of activators and inhibitors to define the properties of the active site of normal and Gaucher disease lysosomal beta-glucosidase.
    Gatt S, Dinur T, Osiecki K, Desnick RJ, Grabowski GA.
    Enzyme; 1985 Mar 16; 33(2):109-19. PubMed ID: 3924590
    [Abstract] [Full Text] [Related]

  • 8. Differentiation of beta-glucocerebrosidase from beta-glucosidase in human tissues using sodium taurocholate.
    Peters SP, Coyle P, Glew RH.
    Arch Biochem Biophys; 1976 Aug 16; 175(2):569-82. PubMed ID: 958319
    [No Abstract] [Full Text] [Related]

  • 9. Effectors of three beta-glucosidases from human liver.
    Daniels LB, Gnarra JR, Glew RH.
    Prog Clin Biol Res; 1982 Aug 16; 95():333-55. PubMed ID: 6812077
    [Abstract] [Full Text] [Related]

  • 10. A revised fluorometric assay for Gaucher's disease using conduritol-beta-epoxide with liver as the source of Beta-glucosidase.
    Daniels LB, Glew RH, Radin NS, Vunnam RR.
    Clin Chim Acta; 1980 Sep 25; 106(2):155-63. PubMed ID: 6773704
    [Abstract] [Full Text] [Related]

  • 11. Human acid beta-glucosidase. Use of conduritol B epoxide derivatives to investigate the catalytically active normal and Gaucher disease enzymes.
    Grabowski GA, Osiecki-Newman K, Dinur T, Fabbro D, Legler G, Gatt S, Desnick RJ.
    J Biol Chem; 1986 Jun 25; 261(18):8263-9. PubMed ID: 3087971
    [Abstract] [Full Text] [Related]

  • 12. Brain glucocerebrosidase in Gaucher's disease.
    Daniels LB, Coyle PJ, Glew RH, Radin NS, Labow RS.
    Arch Neurol; 1982 Sep 25; 39(9):550-6. PubMed ID: 6810854
    [Abstract] [Full Text] [Related]

  • 13. Demonstration of the existence of a second, non-lysosomal glucocerebrosidase that is not deficient in Gaucher disease.
    van Weely S, Brandsma M, Strijland A, Tager JM, Aerts JM.
    Biochim Biophys Acta; 1993 Mar 24; 1181(1):55-62. PubMed ID: 8457606
    [Abstract] [Full Text] [Related]

  • 14. Gaucher's disease II. Studies on the kinetics of beta-glucosidase and the effects of sodium taurocholate in normal and Gaucher tissues.
    Choy FY, Davidson RG.
    Pediatr Res; 1980 Jan 24; 14(1):54-9. PubMed ID: 6767218
    [Abstract] [Full Text] [Related]

  • 15. Effect of a heat-stable factor in human placenta on glucosylceramidase, glucosylsphingosine glucosyl hydrolase, and acid beta-glucosidase activities.
    Vaccaro AM, Muscillo M, Tatti M, Salvioli R, Gallozzi E, Suzuki K.
    Clin Biochem; 1987 Dec 24; 20(6):429-33. PubMed ID: 3124976
    [Abstract] [Full Text] [Related]

  • 16. Comparison of N-acyl phosphatidylethanolamines with different N-acyl groups as activators of glucocerebrosidase in various forms of Gaucher's disease.
    Basu A, Prence E, Garrett K, Glew RH, Ellingson JS.
    Arch Biochem Biophys; 1985 Nov 15; 243(1):28-34. PubMed ID: 3933429
    [Abstract] [Full Text] [Related]

  • 17. Multiple forms of beta-glucosidase in Gaucher disease.
    Yaqoob M, Carroll M.
    Prog Clin Biol Res; 1982 Nov 15; 95():453-63. PubMed ID: 6812081
    [No Abstract] [Full Text] [Related]

  • 18. An improved fluorometric leukocyte beta-glucosidase assay for Gaucher's disease.
    Daniels LB, Glew RH, Diven WF, Lee RE, Radin NS.
    Clin Chim Acta; 1981 Sep 15; 115(3):369-75. PubMed ID: 6794954
    [Abstract] [Full Text] [Related]

  • 19. In vivo inactivation of glycosidases by conduritol B epoxide and cyclophellitol as revealed by activity-based protein profiling.
    Kuo CL, Kallemeijn WW, Lelieveld LT, Mirzaian M, Zoutendijk I, Vardi A, Futerman AH, Meijer AH, Spaink HP, Overkleeft HS, Aerts JMFG, Artola M.
    FEBS J; 2019 Feb 15; 286(3):584-600. PubMed ID: 30600575
    [Abstract] [Full Text] [Related]

  • 20. Activity of glucocerebrosidase in extracts of different cell types from type 1 Gaucher disease patients.
    Sa Miranda MC, Aerts JM, Pinto R, Fontes A, de Lacerda LW, van Weely S, Barranger J, Tager JM.
    Clin Genet; 1990 Sep 15; 38(3):218-27. PubMed ID: 2225530
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.